ConductScience.org, home

Paper80576

Aminoglutethimide in treatment of metastatic breast carcinoma.

Smith IE and 8 others. Lancet, 1978. Cited by 89 papers, by iCite.

Cite this record

ConductScience Library. Aminoglutethimide in treatment of metastatic breast carcinoma. Papers, record 80576. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/80576

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Aminoglutethimide in treatment of metastatic breast carcinoma.
PubMed
Journal
Lancet
PubMed
Year
1978
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
89
iCite
Relative citation ratio, by iCite
3.56
iCite
Revised in PubMed
2019-06-10
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Smith IEI E
2Fitzharris BMB M
3McKinna JAJ A
4Fahmy DRD R
5Nash AGA G
6Neville AMA M
7Gazet JCJ C
8Ford HTH T
9Powles TJT J

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AminoglutethimideMajor topic
Bone NeoplasmsMajor topic
Breast NeoplasmsMajor topic
Liver NeoplasmsMajor topic
Lung NeoplasmsMajor topic
Soft Tissue NeoplasmsMajor topic
Administration, Oral
Adrenal Cortex Hormones
Aged
Drug Evaluation
Female
Humans
Middle Aged
Neoplasm Metastasis
Neoplasm Recurrence, Local

Source PubMed

Download CSV of topics

Cited by17

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 89 citations.

PMIDTitleJournalYearIn PapersSource
34198684Sex Hormones Related Ocular Dryness in Breast Cancer Women.J Clin Med2021https://conductscience.org/library/papers/34198684PubMed
29719441Aromatase inhibitors in premenopausal women with breast cancer: the state of the art and future prospects.Curr Oncol2018https://conductscience.org/library/papers/29719441PubMed
25032258Status of adjuvant endocrine therapy for breast cancer.Breast Cancer Res2014https://conductscience.org/library/papers/25032258PubMed
18500381Indirect androgen doping by oestrogen blockade in sports.Br J Pharmacol2008https://conductscience.org/library/papers/18500381PubMed
7348572Medical adrenalectomy in patients with advanced breast cancer resistant to anti-oestrogen treatment.Breast Cancer Res Treat1981https://conductscience.org/library/papers/7348572PubMed
7126424Polymorphically acetylated aminoglutethimide in humans.Br J Cancer1982https://conductscience.org/library/papers/7126424PubMed
6797571Tamoxifen versus aminoglutethimide in advanced breast carcinoma: a randomized cross-over trial.Br Med J (Clin Res Ed)1981https://conductscience.org/library/papers/6797571PubMed
6684948Aminoglutethimide induced hormone suppression and response to therapy in advanced postmenopausal breast cancer.Br J Cancer1983https://conductscience.org/library/papers/6684948PubMed
6293627Suppression of estrogens with aminoglutethimide and hydrocortisone (medical adrenalectomy) as treatment of advanced breast carcinoma: a review.Breast Cancer Res Treat1981https://conductscience.org/library/papers/6293627PubMed
6277358Effects of endocrine therapy on steroid-receptor content of breast cancer.Br J Cancer1982https://conductscience.org/library/papers/6277358PubMed
4015950Effective inhibition by low dose aminoglutethimide of peripheral aromatization in postmenopausal breast cancer patients.Br J Cancer1985https://conductscience.org/library/papers/4015950PubMed
3978028Observations on the pharmacokinetics of low dose aminoglutethimide in patients with advanced breast cancer.Br J Cancer1985https://conductscience.org/library/papers/3978028PubMed
2963170On the role of additive hormone monotherapy with tamoxifen, medroxyprogesterone acetate and aminoglutethimide, in advanced breast cancer.Klin Wochenschr1987https://conductscience.org/library/papers/2963170PubMed
2933050A comparison of the endocrine effects of low dose aminoglutethimide with and without hydrocortisone in postmenopausal breast cancer patients.Br J Cancer1985https://conductscience.org/library/papers/2933050PubMed
2322991Treatment of advanced breast cancer in postmenopausal women with 4-hydroxyandrostenedione.Cancer Chemother Pharmacol1990https://conductscience.org/library/papers/2322991PubMed
2149401Influence of aminoglutethimide on plasma levels of medroxyprogesterone acetate.Med Oncol Tumor Pharmacother1990https://conductscience.org/library/papers/2149401PubMed
2145964The clinical and endocrine effects of 4-hydroxyandrostenedione alone and in combination with goserelin in premenopausal women with advanced breast cancer.Br J Cancer1990https://conductscience.org/library/papers/2145964PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/80576

GET https://conductscience.org/api/papers/v1/80576/authors